Cell Therapy Manufacturing & Gene Therapy Congress is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Real-World Insights. Trusted Resources. Novel Solutions.


Manufacturing and Process Development – Analytical Strategies, QbD and Cost of Goods
  • Get top tips on monitoring quality across the process with automated analytics 
  • Dive into costs of goods calculations and considerations
  • Hear from Allogene,  Cellectis and Shire
View the manufacturing and process development agenda
Facility Design, Manufacturing Networks and End to End Solutions for Commercial Success
  • Keep abreast of affordable and scalable manufacturing strategies
  • Insourcing vs. outsourcing- What's the right path for you?
  • Top tips from Pluristem, Unum and CCRM
View the facility design, manufacturing networks and end to end solutions agenda
Clinical Development for Cell, Gene and Immunotherapies
  • Get the latest on development pipelines – discover NKs, TILs, MILs, TCRs and more... 
  • Pick up knowledge on process validation and supply chain strategies in the clinic
  • Insights from MPA, TC Biopharm and GenSight
View the clinical development for cell, gene and immunotherapies agenda
Logistics, Supply Chain, and Cryopreservation
  • Immerse yourself in vein-to-vein supply chain and transportation considerations 

  • Explore the effects of freezing and thawing on cell viability 

  • Feedback from Kite, Ossium and Celyad

View the logistics, supply chain and cryopreservation agenda
Additional Learning Opportunities: Pre - conference workshops
  • NEW FOR 2018: Raw Materials Focus Day 
  • Comparability for ATMPs
  • Case studies from Novartis, NIBSC and Juno
View pre-conference focus day agenda
NEW FOR 2018: Visit Sanquin's GMP Facility
  • 2 hour exclusive tour of their new, state of the art, facility
  • Blood bank, reagents, diagnostics and the cell therapy lab
  • Places are capped at 25 (only valid for those attending raw materials session)

Cell Therapy Manufacturing and Gene Therapy Plenaries

Day 1: Opening Plenary

Start the day with a strategical discussion on how we should be designing our manufacturing facilities of the future and our delivery into healthcare 

  • How could innovation lead to a more flexible process and control across supply chains?
  •  What is needed from industry to make it possible to treat multiple patients?
View the opening plenary agenda
Day 1: Closing Plenary

Come together at the end of Day 1 for an inspirational talk .... we want to make it special so are still working towards getting the best speaker for you... 

View the closing plenary agenda
Day 2: Morning Plenary

Our final plenary examines the current regulatory hurdles facing those in the industry…

  • What are the current regulatory challenges in ATMP development
  • A closer look at the proposed global changes to requirements surrounding GMP inspections – expectations and impact
View the plenary agenda